🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07081399
Recruiting Phase EARLY_PHASE1

the Effect of Adult Intubated Patient Clinical Pathway on Post-extubation Complications Prevention

NCT07081399 · tracked via the Priya Life Science Egypt tracker
Phase
Phase EARLY_PHASE1
Started
2024-08-08
Last updated
2025-07-23

Condition(s) studied

DysphagiaDysphagia Rehabilitation

Investigational drug(s) / intervention(s)

ETT cuff pressure monitoring, ETT suctioning, cough augmentation technique, swallowing exercises,: Nebulized budesonide 1mg and IV methylprednisolone 40 mg we

ETT cuff pressure monitoring, ETT suctioning, cough augmentation technique, swallowing exercises,: Nebulized budesonide 1mg and IV methylprednisolone 40 mg we: cough augmentation, larson maneuver, swallowing rehabilitation

Study summary

Post- extubation complications delay the complete recovery of critically ill patient. The clinical pathway is one strategies that help to manage and control these complications.

Eligibility

Sex
ALL
Min age
18 Years
Max age
60 Years
Healthy volunteers
No
Inclusion Criteria: * Adult (\>18 years) * orally intubated patients for the first time attached with MV for less than two weeks * with Glasgow coma scale (GCS) from 13-15. Exclusion Criteria: * patients admitted with high risk for laryngeal edema, * difficult intubation, * ETT/anterior-posterior diameter ˃45%, * self-extubation, and * planned for tracheostomy.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Faculty of Nursing, Damanhour University Damanhūr Egypt Recruiting

More Damanhour University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07081399 on ClinicalTrials.gov ↗ ← All trials in Egypt